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Collagen is a widely used biomaterial in cardiac tissue engineering studies. However, as a natural material, it suﬀers from variability
between batches that can complicate the standardization of culture conditions. In contrast, synthetic materials are modi�able,
have well-de�ned structures and more homogeneous batches can be produced. In this study, several collagen-like synthetic
self-assembling nano�ber hydrogels were examined for their suitability for cardiomyocyte culture in 2D and 3D. Six diﬀerent
nano�ber coatings were used in the 2D format with neonatal rat cardiomyocytes (NRCs) and human embryonic stem-cell-derived
cardiomyocytes (hESC-CMs).e viability, growth, and functionality of the 2D-cultured cardiomyocytes were evaluated.e best-
performing nano�ber coatings were selected for 3D experiments. Hydrophilic pH-sensitive nano�ber hydrogel coassembled with
hyaluronic acid performed best with both NRCs and hESC-CMs. Hydrophilic non-pH-sensitive nano�ber hydrogels supported
the growth of NRCs; however, their ability to promote attachment and growth of hESC-CMs was limited. NRCs also grew on
hydrophobic nano�ber hydrogels; however, the cell-supporting capacity of these hydrogels was inferior to that of the hydrophilic
hydrogel materials. is is the �rst study demonstrating that hydrophilic self-assembling nano�ber hydrogels support the culture
of both NRCs and hESC-CMs, which suggests that these biomaterials hold promise for cardiac tissue engineering.
1. Introduction
Heart failure arising from myocardial loss is a leading cause
of morbidity and mortality worldwide [1] for which stem
cell therapy is an emerging treatment option. For treatment
of heart failure, cells can potentially be delivered to the
site of injury where they can repopulate the injured area,
integrate into the host tissue, and restore functionality to
the myocardium. However, clinical studies have shown that
cells delivered by direct injection into the myocardium or
by intracoronary injection are rapidly lost [2–4]. Modest
improvements in myocardial function have been suggested
to merely arise from paracrine eﬀects [5–7]. To achieve the
desired cellular eﬀects in addition to the paracrine eﬀects,
biomaterial scaﬀolds can be used to maintain the cells at the
site of injection.
An ideal biomaterial scaﬀold for cardiac repair would
allow cardiomyocytes to be grown in vitro in a 3D structure
that is optimal for application to the heart, allows cellular
diﬀerentiation, and integrates well into the host tissue aer
implantation. In addition to clinical cell therapy applications,
3D structures can also provide better cardiac tissue models
for studying the pathophysiology of cardiac diseases and the
function of diseased cardiomyocytes in vitro. Additionally,
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these 3Dmodelsmay providemoremeaningful physiological
data in drug discovery and toxicology assays.
Beating cardiac constructs have been obtained using
collagen patches [8], poly(N-isopropylacrylamide) sheets [9],
collagen rings [10], collagen sponges [11], and injectable
�brin gels [12]. Scaﬀold-free human cardiac tissue has also
been generated [13]. In our previous studies, we compared
diﬀerent synthetic and natural biomaterials for their ability to
support cardiomyocyte growth [14]. Of the biomaterials we
tested, natural collagen supported cardiomyocyte growth the
best but showed signi�cant batch-to-batch variation. us,
we continued to search for synthetic alternatives to collagen
that had similar bioactivity but less variability.
Previously, we tested the commercially available amphi-
philic self-assembling peptide PuraMatrix (BD Biosciences).
Although PuraMatrix was shown to be less eﬀective than
collagen at supporting the growth and survival of cardiomy-
ocytes, it performed well enough to attract our interest in this
class of materials [14]. We previously reported the develop-
ment of self-assembling nano�ber systems with a modular
architecture based on a 1,3,5-triamide cis,cis-cyclohexane
core [15]. is core functions as a generic nano�ber-forming
scaﬀold that can be easily functionalized and tuned [15–
17]. We demonstrated that vesicles can be easily entrapped
and immobilized in hydrogels generated from thesematerials
[18], thereby providing a system to study the activity ofmem-
brane proteins at the single vesicle level [19]. Preliminary in
vitro and in vivo experiments indicated that hydrogels formed
from these compounds are biocompatible [15, 20], which
encouraged us to study their use as coatings and hydrogel
scaﬀold materials for the growth of cardiomyocytes.
e aim of this study was to screen diﬀerent self-as-
sembling nano�ber hydrogels as 2D nano�ber coatings for
cardiomyocyte attachment and growth and to then further
evaluate the best candidates for use as 3D nano�ber hydro-
gels. To assess the performance of our nano�ber materials
we used NRCs and hESC-CMs, and we considered that an
optimal biomaterial should support routine cardiomyocyte
attachment, growth, and function. NRCs were used because
they can be obtained fairly easily in large numbers, which
enabled us to perform large-scale comparison experiments
[21] before testing hESC-CMs. It has also been shown that 3D
heart tissue-like structures can be created with NRCs [10, 22]
and with hESC-CMs [22–24].
ree diﬀerent types of self-assembling nano�ber hydro-
gels were examined: hydrophilic pH-sensitive, hydrophilic
non-pH-sensitive, and very hydrophobic non-pH-sensitive,
hydrogels. We also tested the eﬀect of �ber thickness on
cell adhesion for the hydrophilic nano�ber hydrogels. In
addition, we tested the eﬀects of pH-sensitive nano�ber




2.1.1. Isolation and Culture of Neonatal Rat Cardiomyocytes.
NRCs were isolated as described previously [26], with minor
modi�cations. Brie�y, rat hearts were harvested from one-
to three-day-old Sprague Dawley rats and then disaggregated
in a collagenase (type 2, Worthington, USA) solution. e
cells were then preplated to allow the nonmyocytes to
attach.eunattachedmyocytes were collected, counted, and
plated onto various nano�ber materials in culture medium I
(CMI, Dulbecco�s Modi�ed Eagle�s Medium/Ham�s Nutrient
Mixture F-12 (DMEM/F-12, Sigma-Aldrich, USA), 10% fetal
bovine serum (FBS, Invitrogen, USA), 100 IU/mL peni-
cillin/0.1mg/mL streptomycin (P/S, Lonza, Belgium), and
2.56mML-glutamine (Sigma-Aldrich)).e cells were plated
at equal numbers on nano�ber test materials and uncoated
commercial 24-well plates (Nunc, ermo Fisher Scienti�c,
USA) (400,000 cells/well for 2D coatings or 800,000 inside
and on top of the gels). e following day and subsequently
every second or third day thereaer, serum-free medium
(SFM, DMEM/F-12, 10% bovine serum albumin (BSA,
Sigma-Aldrich), 2.8mM sodium pyruvate (Lonza), 2.56mM
L-glutamine, insulin-transferrin-sodium selenite media sup-
plement (ITS, Lonza; 1 𝜇𝜇M insulin, 5.64 𝜇𝜇g/mL transferring,
32 nM selenium), and 100 IU/mL P/0.1mg/mL S, 0.1 nM 3,
3�, 5-Triiodo-L-thyronine sodium salt (T3, Sigma-Aldrich))
was changed. e NRCs were cultured for one week.
2.1.2. Culture and Diﬀerentiation of Human Embryonic Stem
Cells. We used the H7 human embryonic stem cell line
(WiCell, USA). H7 cells were cultured on top of mouse
embryonic �broblasts (MEFs, Millipore, France/USA) in
KSR medium (Knockout DMEM (Invitrogen), 20% serum
replacement (SR, Invitrogen), 2mM GlutaMax (Invitrogen),
1% nonessential amino acids (NEAA, Lonza), 50U/mL
P/S, 0.1mM 2-mercaptoethanol (Invitrogen), and 8 ng/mL
basic �broblast growth factor (bFGF, R�D Systems, USA))
to maintain their pluripotency [27]. e cells were enzy-
matically passaged once a week using type IV collagenase
(1mg/mL, Invitrogen).
Diﬀerentiation was induced by coculturing the stem cells
with END-2 cells [28] in 0% KO-SR hES medium (Knockout
DMEM, 2mM GlutaMax, 1% NEAA, 50 U/mL P/S, 0.1mM
2-mercaptoethanol) which was changed on days 5, 8, and 12.
On day 15, the medium was replaced with 10% KO-SR hES
medium (Knockout DMEM, 10% SR, 2mM GlutaMax, 1%
NEAA, 50U/mL P/S, 0.1mM 2-mercaptoethanol) that was
replenished every third day thereaer. e �rst beating areas
normally appeared aer 14 days of diﬀerentiation. When the
cells had been diﬀerentiated for 20 to 55 days, they were
dissociated into single cells. Approximately the same amount
(approximately 4,000) of cells was plated on each coating, on
top of or inside the gels, and on control wells (0.1% gelatin
(Sigma-Aldrich) coated commercial 24- or 48-well plates).
e hESC-CMs were usually cultured for one week.
2.2. Cell Characterization. Cells were plated at equal num-
bers onto nano�ber hydrogels and control wells. e cells
were observed daily using a phase-contrast microscope
(Nikon Eclipse TS100, Nikon, Japan) and several qualita-
tive parameters were scored to determine the suitability of
nano�ber hydrogels for supporting cardiomyocyte culture.















F 1: A schematic representation of gelation through self-assembly.
ese parameters included cell attachment, spreading, mor-
phology, viability, detachment, and beating. Staining for
cardiomyocyte markers was used to evaluate the alignment
and spreading of cardiomyocytes. Cell attachment was also
evaluated quantitatively by counting troponin T positive
cells.WithNRCs, cell attachmentwas evaluated bymeasuring
the con�uency of troponin-positive cells/well, whereas with
hESC-CMs all troponin-positive cells from every replicate
were calculated.
2.2.1. Viability. e LIVE/DEAD Viability/Cytotoxicity Kit
for mammalian cells (Molecular Probes, Inc., Invitrogen),
which contains calcein AM to stain live cells green and
ethidium homodimer-1 to stain dead cells red, was used to
assess viability. e stained cells were observed using phase
contrast and �uorescencemicroscopy (Olympus I�51,Olym-
pus, Japan) and photographed using an Olympus DP30BW
camera (Olympus, Japan).
2.2.2. Immunocytochemical Staining. e cells were �rst
�xed with 4% paraformaldehyde (Fluka, Italy) at room
temperature for 20 minutes and then blocked at room
temperature for 45 minutes prior to labeling with primary
antibodies (mouse monoclonal to myosin ventricular heavy
chain alpha/beta (MHC) (1 : 100) (Chemicon Temecula,
USA), mouse monoclonal to myosin-speci�c ventricle of the
mammalian heart (MLC2v) (1 : 100) (Synaptic Systems, Ger-
many), and goat polyclonal to cardiac troponin T (1 : 2000)
(Abcam, UK)) at 4∘C overnight. Cells were then labeled with
secondary antibodies (Alexa 488 anti-mouse donkey (1 : 400,
1 : 800) (Invitrogen) or Alexa 568 anti-goat donkey (1 : 400,
1 : 800) (Invitrogen)) at room temperature for 2 hours. DAPI
(4,6�-diamidino-2-phenylindole)was used to stain the nuclei.
e cells were visually observed and photographed using the
same equipment described for LIVE/DEAD staining.
2.3. Synthesis o� Sel���ssembling �ano�ber �y�rogels. Self-
assembling nano�ber hydrogels (Figure 1) were synthesized
according to previously described methods [15, 16]. Self-
assembling nano�ber hydrogels 1–6 were used in this study,
and their structural formulas and �ber properties are listed in
Table 1.
2.3.1. Cryogenic Transmission Electron Microscopy. Several
microliters of the nano�ber suspensions were deposited on
bare 700 lines/inch mesh copper grids. Aer excess liquid
was blotted away, the grids were plunged quickly into liquid
ethane. Frozen-hydrated specimens weremounted on a cryo-
holder (Gatan, model 626) and observed using a Philips CM
120 electron microscope operated at 120 kV. Micrographs
were recorded under low-dose conditions using a slow-scan
CCD camera (Gatan, model 794).
2.3.2. �reparation o� 2� �ano�ber Coatings o� p��Sensiti�e
�elators ��ano�ber Coatings 1� 2�. A solution of 10mg of the
HCl salt (Boom B.V.,e Netherlands) of the gelator in 3 mL
of mQ water was prepared by gentle heating. e solution
was neutralized by addition of 1mL of 100mM HEPES,
pH 8 (Sigma-Aldrich). Aliquots of the 200 𝜇𝜇L neutralized
solution were transferred to wells of a 24-well plate (SPL
Life Sciences, Inc., the Republic of Korea). e solvent was
evaporated overnight under ambient conditions to yield
transparent to translucent coatings. e �brous nature of
the coatings was con�rmed by optical microscopy (Motic
AE31, China). Before use, the plates were sterilized for
5 minutes with UV light irradiation in a laminar �ow
cabinet. Nano�ber coating 1was tested using both NRCs and
hESC-CMs and nano�ber coating 2 was tested using hESC-
CMs.
2.3.3. �reparation o� �y��Containing 2� �ano�ber Coatings
o� p��Sensiti�e �elators ��ano�ber Coatings 1 + HyA, 2 +
HyA). A solution of 10mg of the HCl salt of the gelator
in 2.6mL mQ water was prepared by gentle heating. To
this solution we added 0.4mL of a 0.5% (w/v) solution of
hyaluronic acid (Sigma-Aldrich) in mQ water. e resulting
solution was neutralized by the addition of 1mL of 100mM
HEPES, pH 8. Aliquots of the 200 𝜇𝜇L neutralized solution
were transferred to the wells of a 24-well plate. e solvent
was evaporated overnight under ambient conditions to yield










































































































































































































































































































































































































































































































































































































































6 BioMed Research International
transparent to translucent coatings. e �brous nature of
the coatings was con�rmed by optical microscopy. Before
use, the plates were sterilized for 5 minutes with UV light
irradiation in a laminar �ow cabinet. Nano�ber coatings 1 +
HyA and 2 + HyA were tested using both NRCs and hESC-
CMs.
2.3.4. Preparation of 2D Coatings of Non-pH-Sensitive Gela-
tors �Nano��er Coatings and 3, 4, 5, 6). A solution of 10mg
of the gelator in 16mL of a 95 : 5 ethanol/water mixture was
prepared by gentle heating. Aliquots of 750 𝜇𝜇L of the stock
solution were transferred to the wells of a 24-well plate. e
solvent was evaporated overnight under ambient conditions
to yield transparent to translucent coatings. e �brous
nature of the coatings was con�rmed by optical microscopy.
Before use, plates were sterilized for 5 minutes with UV light
irradiation in a laminar �ow cabinet. Nano�ber coatings 3,
5, and 6 were tested using both NRCs and hESC-CMs and
nano�ber coating 4 was tested using hESC-CMs.
2.3.�. Preparation of 3D Nano��er Hydrogels. Based on the
results from the 2D experiments, the nano�ber coatings 1
+ HyA and 4 were chosen for the 3D nano�ber hydrogel
experiments.Nano�ber hydrogel 1was included in the hESC-
CM experiments to control for the eﬀects of HyA addition.
e 3D nano�ber hydrogels 1 + HyA and 4 were �rst studied
using NRCs and then using hESC-CMs.
e gelators were dissolved in DMSO (Sigma-Aldrich)
(4: 100–197mg/mL) or 0.21M HCl (1: 130mg/mL). When
usingHyA in addition to the nano�ber hydrogel, theHyAwas
�rst diluted in medium (5mg/mL). e gel stock and HyA
solutions were then sterilized with UV light for 5 minutes.
Finally, the gel stock solutions were diluted inmedium (either
with or without the cells) in a ratio of 1 : 9. If the medium did
not contain cells, the cells were subsequently plated on top of
the nano�ber hydrogels.
2.4. Statistics. Statistical signi�cance for cell attachment was
analyzed usinge Kruskal-Wallis andMann-Whitney tests.
3. Results
3.1. Nano��ers. e properties of the nano�ber hydrogels
have been previously described in detail [15, 16]. Brie�y, the
nano�ber hydrogels are thermoreversible and their stability
can be adjusted by adding amino-acid-based substituents.
e substituents also aﬀect the responsiveness of the hydrogel
to pH changes [15], which results in hydrogels that are pH
sensitive or non-pH sensitive (Table 1). e pH-sensitive
nano�ber hydrogels are positively charged and the non-
pH-sensitive hydrogels are neutral. e positively charged
pH-sensitive hydrogels can be coassembled with negatively
charged HyA by electrostatic interaction.
Nano�ber hydrogels have �bers thicknesses that range
from nanometers to micrometers (Table 1) and they form
�brous gel networks [15, 16]. e �ber surfaces are either
cationic (positively charged) or protic (protons on the sur-
faces that exchange with water) (Table 1).
3.2. Cryogenic Transmission Electron Microscopy. Whereas
gelators 1, 3, 4, and 5 all produced very similar �ber surfaces
with terminal hydrophilic alcohol groups reminiscent of
polyethylene glycol, the self-assembly process for these four
compounds resulted in �bers with pronounced diﬀerences
in morphology. us, this series of compounds was studied
to investigate the eﬀects of similar surface chemistry but
diﬀerent morphology on cellular attachment. Cryogenic
transmission electron microscopy (Cryo-TEM) was used to
characterize the diﬀerences in �ber morphology for these
four compounds. Compound 1 was previously reported to
self-assemble into tubular �bers with a diameter of approx-
imately 4.2 nm and a very homogeneous distribution [16].
Figure 2 shows that compound 3 self-assembles into bundles
of �bers with a diameter of approximately 13 nm. Compound
4 self-assembles into ribbons of uniform thickness that are
approximately 50–200 nm wide. Compound 5 self-assembles
into sheets of uniform thickness with widths of 100 nm to
3 𝜇𝜇m.
3.3. 2𝐷𝐷 Nano��er Coatings. e cells were cultured on the
nano�ber coatings for seven days, a�er which they were
stained with the LIVE/DEAD kit or �xed and stained with
cardiac-speci�c antibodies (troponin T, MHC or MLC2v).
e suitability of nano�ber coatings for cardiomyocyte cul-
ture was evaluated by observing cell attachment, spreading,
morphology, viability, detachment, and beating in compari-
son to cells cultured on control surfaces (NRCs on untreated
commercial well plates and hESC-CMs on 0.1% gelatin-
coated commercial well plates).e results for the evaluation
criteria for each material are summarized in Table 1. In
addition, cell attachmentwas quanti�ed (Figures 3 and 4), but
no statistical signi�cance was detected.
e ratio between live and dead cells for both cell types
was almost the same on every nano�ber coating. Approxi-
mately 70% of cells were alive and 30% were dead (Figures
5(f) and 5(l)).
3.3.1. Neonatal Rat Cardiomyocytes. ere were no major
diﬀerences in cell growth among the nano�ber coatings when
culturing NRCs. Nano�ber coatings 1 (𝑛𝑛 𝑛 𝑛, Figure 5(b)), 1
+ HyA (𝑛𝑛 𝑛 𝑛, Figure 5(c)), 3 (𝑛𝑛 𝑛 𝑛, Figure 5(d)), and 5
(𝑛𝑛 𝑛 𝑛) supported the growth of the NRCs equally as well
as the control surface (𝑛𝑛 𝑛 𝑛, Figure 5(a)). e cells spread
evenly and their morphology was the same as the cells in the
control wells. Most of the cells remained attached throughout
the entire culture period (Figure 3). e beating rate and
strength were similar between nano�ber coatings and control
wells.
Nano�ber coatings 6 (𝑛𝑛 𝑛 𝑛) and 2 + HyA (𝑛𝑛 𝑛 𝑛,
Figure 5(e)) did not support the growth of NRCs as
well as the control surface and the cells did not attach
properly on these coatings (Figure 3). Also the attached
cells tended to detach over time. At day 7, most of the
cells had detached and formed aggregates on the coatings
(Figure 5(e)). Additionally, cells were not as evenly spread
on these nano�ber coatings as on the control surface
(Figure 5(a)).




F 2: Cryo-TEM images of nano�ber hydrogels 3 (0.03wt%,
(a)), 4 (0.2 wt%, (b)), and 5 (0.05wt%, (c)). Scale bars represent
100 nm.
3.3.2. Human Embryonic Stem-Cell-Derived Cardiomyocytes.
Hydrophilic nano�ber coatings 1 + HyA (𝑛𝑛 𝑛 𝑛, Figure 5(h))
and 4 (𝑛𝑛 𝑛 𝑛, Figure 5(i)) were best suited for supporting
hESC-CMs.e cells attached well and they spread as evenly
on the nano�ber surfaces as on the gelatin control surface
(𝑛𝑛 𝑛 𝑛, Figure 5(g)). Nano�ber coating 1 + HyA supported
the growth of hESC-CMs throughout the entire culture
period of seven days. Nano�ber coating 4 also supported
the growth and survival of the cells, although initially cells
needed a few days to adapt to this coating. Once adapted, the
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F 4: Cell attachment was determined by calculating the
amount of troponin-T-positive hESC-CMs on each material. How-
ever, cell attachment was not the only criteria for optimal material
and thus despite good attachment some nano�ber coatings were
not optimal supporters for cardiomyocyte culture (for details, see
Section 3).
Nano�ber coatings 5 (𝑛𝑛 𝑛 𝑛, Figure 5(j)) and 2 +
HyA (𝑛𝑛 𝑛 𝑛) modestly supported hESC-CM growth. On
nano�ber coating 5 (Figure 5(j)), there were fewer hESC-
CMs attached and the attached cells were smaller than those
on the control surface (Figure 5(g)). Nano�ber coating 2 +
HyA did not perform well initially, but towards the end of
the culture period, the hESC-CMs adapted and spread well
on this surface.
Nano�ber coatings 1 (𝑛𝑛 𝑛 𝑛), 2 (𝑛𝑛 𝑛 𝑛), 3 (𝑛𝑛 𝑛 𝑛), and
6 (𝑛𝑛 𝑛 𝑛) did not support the growth of hESC-CMs. e
cells either did not attach at all or they detached shortly aer
attachment. Some attached cells remained spherical and did
not spread on the nano�ber coatings. On nano�ber coating
6, the cells surrounded the nano�ber particles rather than
growing on top of them (Figure 5(k)).


















F 5: Cardiomyocytes on diﬀerent nano�ber coatings stained positively using ((a)–(e), (g)–(k)) cardiac antibodies or ((f), (l))
LIVE/DEAD Kit. Red is ((a)–(e), (g)–(k)) troponin T, green is (g) MLC2v or ((h)–(k)) MHC, and blue is DAPI (nuclei). NRCs grew as
well on top of nano�ber coatings (b) 1 (𝑛𝑛 𝑛 𝑛), (c) 1 + HyA (𝑛𝑛 𝑛 𝑛), and (d) 3 (𝑛𝑛 𝑛 𝑛) as on (a) the control (untreated commercial well plate,
𝑛𝑛 𝑛 𝑛), whereas on (e) 2 + HyA (𝑛𝑛 𝑛 𝑛) they did not attach well and formed clusters. Cardiomyocytes diﬀerentiated from hESCs grew well
on top of nano�ber coatings (h) 1 + HyA (𝑛𝑛 𝑛 𝑛) and (i) 4 (𝑛𝑛 𝑛 𝑛) and fairly well on nano�ber coating (�) 5 (𝑛𝑛 𝑛 𝑛) when compared to (g)
the control (commercial well plate coated with 0.1% gelatin, 𝑛𝑛 𝑛 𝑛). �n nano�ber coating (k) 6 (𝑛𝑛 𝑛 𝑛), the cells did not grow on top of the
coating, but they surrounded it.e round structure (∗) is a particle of the coating.e ratio between living and dead cells was approximately
the same on every coating with both (f) NRCs and (l) hESC-CMs. e same scale bar (200 𝜇𝜇m) applies to every image.
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Nano�ber coatings 1 + HyA and 4 were evaluated as
the best ones due to the cell attachment calculations (Figure
4) and other evaluated criteria (namely, cell spreading,
morphology, viability, detachment, and beating; Table 1).
Although nano�ber coating 2 had higher median cell attach-
ment than 1 + HyA and 4, it was classi�ed as one of the least
supportive coatings because the morphology of the cells was
not the same as on the controls but spherical and they did not
spread on the coating. In addition, there was high variation
on cell attachment. Also nano�ber coatings 1, 3, and 6 were
classi�ed as the least supportive materials, not according to
the amount of cells attached (Figure 4) but according to other
evaluation criteria listed above (Table 1).
3.4. 3𝐷𝐷 Nano�ber Hydro�els. Nano�ber coatings 1 + HyA
and 4 were chosen for the nano�ber hydrogel experiments
because of their superior performance in the 2D coating
experiments with hESC-CMs. Nano�ber coating 1 was also
investigated as a control for the nano�ber hydrogel 1 + HyA.
e purpose of the 3D experiments was to see how well the
2D results translated to 3D. e same evaluation parameters
were used as in the 2D coating experiments. One additional
parameter was used, that is, degradation of the hydrogels.
LIVE/DEAD staining could not be used because of high
background.
3.4.1. Neonatal Rat Cardiomyocytes. NRCs grewwell both on
top of and inside the nano�ber hydrogels. Nano�ber hydrogel
1 + HyA (𝑛𝑛 𝑛 3) performed well and was stable for the entire
duration of the experiment (7 days). Nano�ber hydrogel 4
(𝑛𝑛 𝑛 3) supported cell growth well but appeared to be better
suited for short-term studies or for other applications, as the
gels started to degrade a few days aer the cells were plated.
e degradation of nano�ber hydrogel 4 was remarkably
faster than that of nano�ber hydrogel 1 + HyA.
3.4.2. Human Embryonic Stem-Cell-Derived Cardiomyocytes.
e three nano�ber hydrogels also supported the growth of
hESC-CMs. All of the tested nano�ber hydrogels allowed the
hESC-CMs to grow and beat on top of the gels aswell as inside
the gels; however, nano�ber hydrogel 4 (𝑛𝑛 𝑛 3) degraded
too rapidly for long-term use (this was also observed for
NRCs). Nano�ber hydrogel 1 + HyA (𝑛𝑛 𝑛 𝑛) performed
better than non-coassembled nano�ber hydrogel 1 (𝑛𝑛 𝑛 3).
In hydrogel 1 + HyA, the cells remained inside the gel,
whereas, in non-coassembled nano�ber hydrogel 1, the cells
tended to migrate through the hydrogel to the bottom of
the wells. In addition, nano�ber hydrogel 1 + HyA was
more robust, as it remained intact for the entire 30-day
duration of the experiment. Furthermore, this hydrogel was
able to maintain the beating capability of the cells (see sup-
porting data (video) in supplementary material available at
doi:10.1155/2012/285678).
4. Discussion
In this paper, we evaluated the suitability of six diﬀerent self-
assembling nano�ber hydrogels for attachment and growth
of NRCs and hESC-CMs, �rst as 2D coatings and then as
3D gels. �e examined nano�ber hydrogels that were pH
sensitive, non-pH sensitive, hydrophilic, and hydrophobic.
Hyaluronic acid was coassembled with the pH-sensitive
hydrogels. Two hydrophilic synthetic nano�ber hydrogels
were found to support human and rat cardiomyocytes in both
2D and 3D culture, thus providing an alternative platform for
in vitro cardiac modeling.
Collagen has been extensively studied as a biomaterial
for cardiac tissue engineering [8, 10, 11]. Although nat-
ural polymers such as collagen may be bene�cial for cell
attachment and diﬀerentiation, they oen do not have the
proper mechanical strength. Batch-to-batch variations [29]
and possible contamination with animal compounds also
raise concerns, especially when considering future clinical
applications. In addition, for proper gelation of collagen,
animal-derived materials such as Matrigel, chick embryo
extract, horse serum, or extracellular matrix (ECM) from
decellularized porcine hearts are added [10, 23]. In contrast,
fully synthetic materials are homogenous, well de�ned, and
have low batch-to-batch variation. Synthetic compounds can
easily be modi�ed using amino-acid-based substituents [15]
and are thus considered to be reliable and customizable
materials for in vitro and clinical applications. Furthermore,
synthetic compounds can be produced without any animal
products, which is desirable for clinical applications.
In our previous study [14], we showed that the growth
of NRCs was best supported by natural collagen. ere-
fore, we wanted to continue our studies using a material
with properties similar to those of natural collagen. Self-
assembling nano�ber hydrogels are an emerging class of syn-
thetic biomaterials that oﬀer highly bioactive nanostructures
that can be of interest for many biomedical applications
[30, 31]. Structurally, self-assembling nano�ber hydrogels
have a strong resemblance to natural collagen and their
biocompatibility has been demonstrated [20]. Hence, these
materials were potentially suitable for supporting the growth
of cardiomyocytes, which was indeed shown in this study.
In our 2D coating experiments, all nano�ber coatings
supported the growth and survival of NRCs. However, two
of the nano�ber coatings supported only limited attachment
and growth of NRCs: one was the hydrophobic non-pH
sensitive nano�ber 6 and the other was the hydrophilic
pH-sensitive nano�ber 2. e best coatings for NRCs were
the hydrophilic pH-sensitive nano�ber coating 1 with or
withoutHyA and the hydrophilic non-pH sensitive nano�ber
coatings 3 and 5. According to these results, hydrophilicity is
more eﬀective at promoting cell attachment and growth than
pH sensitivity. However, pH-sensitive nano�ber hydrogels
are positively charged and are therefore expected to provide
greater cell attachment because cells have negatively charged
surfaces. In these experiments, pH sensitivity seemed towork
well when combined with hydrophilicity.
For hESC-CMs, the diﬀerences in cell attachment and
survival among 2D nano�ber coatings were more pro-
nounced. e nano�ber 1 hydrogel with hydrophilic �ber
surface provided the best attachment and growth support also
for human cardiomyocytes.e addition ofHyA to nano�ber
coating 1 further improved cell attachment and survival and
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also provided the best support for cells in 3D. Hyaluronic
acid is one of the components of the ECM. erefore, it
was presumed that HyA improved cell attachment [32] as
well as cell proliferation and migration [33]. It would have
been interesting to see how the addition of HyA to other
nano�ber hydrogels aﬀects cell attachment and survival, but it
is possible to co-assemble negatively charged HyA only with
positively charged pH-sensitive hydrogels.
e nano�ber hydrogel 2 (± HyA) did not support the
growth of cardiomyocytes; only NRCs grew on this material
to some extent. e �ber surfaces of this hydrogel are lysine-
terminated and thus similar to polylysine surfaces in terms of
chemistry. Polylysine is considered favorable in terms of cell
attachment.e attachment mechanism of cells to polylysine
has not been fully elucidated, but it is usually considered
to involve an electrostatic interaction between anionic cell
surfaces and the cationic polylysine surface [34]. erefore,
nano�ber hydrogel 2 surface was expected to enhance cell
attachment more eﬀectively than other surfaces, but this was
not observed, which could be due to the more basic nature of
nano�ber hydrogel 2 than polylysine. Nano�ber hydrogel 6
was also unsuitable for supporting cardiomyocytes; however,
this hydrogel has a very hydrophobic �ber surface and thus
these results were expected.
Nano�ber hydrogels 1, 3, 4, and 5 all have very similar
�ber surfaces, but the �ber thicknesses vary, which allowed
us to examine the eﬀects of similar surface chemistries
and diﬀerent �ber morphologies on cellular attachment. �e
varied the thickness of the �bers� 1 (4.2 nm), 3 (13 nm), 4
(50–200 nm), and 5 (100 nm–3 𝜇𝜇m). For comparison, colla-
gen �bers are 1–20 𝜇𝜇m thick and elastin �bers are 0.2–1.5𝜇𝜇m
thick [35]. Nano�bers in hydrogel 5 formed sheets which
thicknesses are similar to the �ber thicknesses of collagen
and elastin. Nano�ber hydrogel 1 had the thinnest �bers. In
our study, nano�ber hydrogel 1 (+ HyA) had the best per-
formance.e second thickest nano�ber hydrogel (nano�ber
hydrogel 4) had �ber sheet thicknesses of 50–200 nm and also
performedwell with hESC-CMs.Amongnano�ber hydrogels
with protic �ber surfaces, �ber thickness had less in�uence
on NRC attachment than HyA addition. However, the �ber
dimensions and the addition of HyA both aﬀected hESC-
CMs attachment.
Some diﬀerences in the results between NRCs and hESC-
CMswere observed, especially in 2D experiments. It has been
reviewed in previous experiments that hESC-CMs are more
sensitive to surrounding biomaterial than other cell types
[36]. NRCs are more robust and also in our experiments
grew better on several nano�ber hydrogels than hESC-CMs.
Shapira-Schweitzer et al. also showed that NRCs are easier
to handle, maturate faster, and contract more eﬀectively than
hESC-CMs [22]. Nevertheless, NRCs can be used as a model
for human cells for preliminary experiments, for example,
to screen diﬀerent biomaterials. is was also demonstrated
in our study as hESC-CMs did not grow well on any of the
materials where NRCs did not grow.
�hen evaluating nano�ber materials as in the present
study, it is important to note that both NRC- and hESC-
derived beating areas contain both cardiomyocytes and
noncardiomyocytes. Consequently, when the beating areas
are dissociated, there is always a mixture of cell types. As a
result, it is currently not possible to obtain pure populations
of human cardiomyocytes for testing. However, the other
cell types existing in the beating areas, such as �broblasts,
have been shown to support cardiomyocyte growth and
functionality [37], which suggests that the mixed popula-
tion of cells in our cultures is bene�cial. Additionally, the
presence of other cell types in cardiac gras (i.e., �broblasts
and endothelial cells (ECs)), has been demonstrated to
improve the vascularization and function of gras in vivo
[38].
As cells grow in 3D in vivo, we wanted to test whether
nano�bers in 3D hydrogels would support cell growth better
than on 2D coatings. However, our results did not sup-
port this hypothesis, possibly because of problems with the
gelation process. e optimal amount of cells needed for
formation of 3D cell structures is also not known. In 3D
hydrogel experiments, some variation from well to well was
observed, mainly because gelation occurred rapidly resulting
in heterogeneous hydrogels. Consequently, in soer parts of
the hydrogels, some of the cells migrated to the bottom of
the wells rather than staying attached to the hydrogel matrix.
e cells that stayed attached to the hydrogels grew well and
retained their beating capability.e heterogeneous nature of
the hydrogels sometimes limited the visualization of the cells.
ere were nomajor diﬀerences in the growth pattern of cells
inside or on top of the diﬀerent nano�ber hydrogels for either
of the cell types.
Not many 3D biomaterial studies have been performed
using hESC-CMs. �ur study is the �rst to demonstrate
the growth of hESC-CMs in 3D self-assembling nano�ber
hydrogels. e �rst 3D vascularized human cardiac tissues
were created by combining hESC-CMs, ECs, and �broblasts
with PLLA(50%)/PLGA(50%) biodegradable scaﬀolds [24].
Transplantation of hESC-CMs in alginate scaﬀolds into
infarcted heart tissue has also been described; however,
this treatment did not promote myogenic diﬀerentiation or
organization of the implanted cells [39]. Furthermore, hESC-
CM function and maturation within PEGylated �brinogen
(PF) hydrogels has been shown. e responsiveness of these
cells to cardiac drugs demonstrated the potential to use
this system for in vitro drug screening [22]. e same
group showed that codelivery of PF matrix with hESC-CMs
into infarcted areas provided additional therapeutic eﬀects
and prevented unfavorable postinfarction cardiac remod-
eling [40]. Madden et al. showed that hESC-CMs seeded
into microtemplated poly(2-hydroxyethyl methacrylate-co-
methacrylic acid) (pHEMA-co-MAA) hydrogels cultured
for 2 weeks could reach adult heart density in vitro.
Additionally, acellular scaﬀolds implanted in rats enhanced
angiogenesis [41]. In one study, porcine heart ECM and
collagen I were used to induce cardiac diﬀerentiation of
hESCs. Hydrogels with diﬀerent ratios of ECM and collagen
were prepared and cardiomyocyte maturation and contrac-
tion were evaluated. Hydrogels with a higher ECM content
promoted cardiac maturation [23]. Human engineered heart
tissue (hEHT) has also been developed from hESC-CMs
and �brinogen; it forms a dense network that responds to
chronotropic compounds [42].
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Based on our study, self-assembling nano�ber hydrogels
can be modi�ed to obtain bene�cial features that support
the growth of cardiomyocytes. To further improve the per-
formance of these synthetic cell-supporting structures, the
gelation procedure should be optimized to allowmore homo-
geneous formation of the hydrogels. Another possibility that
we are now investigating is decoration of the self-assembling
nano�ber hydrogels with functional groups (e.g., the RGD
peptide sequence) to improve cell adhesion. Finally, because
amain application for 3D cardiac tissue is drug discovery and
testing, the possibility of measuring signals from hESC-CMs
in a 3Dhydrogel using amicroelectrode array (MEA) is under
investigation.e suitability ofMEAplatforms formeasuring
drug responses of hESC-CMs has been shown in 2D culture
[28, 43, 44].
5. Conclusions
In our previous study, we compared diﬀerent natural and
synthetic biomaterials for cardiomyocyte culture. Collagen
type I best supported the growth of cardiomyocytes. How-
ever, as a natural material, collagen has batch-to-batch
variations. We therefore decided to investigate a synthetic
material similar to collagen. In this study, neonatal rat
cardiomyocytes and human embryonic stem-cell-derived
cardiomyocytes were grown on diﬀerent synthetic self-
assembling nano�ber hydrogels. e pH-sensitive nano�ber
hydrogel with hydrophilic and protic �ber surfaces and
coassembled with hyaluronic acid best supported the growth
of rat and human cardiomyocytes.ese nano�ber hydrogels
are promisingmaterials for the development of future cardiac
tissue models.
Con�ict of �nterests
e author declare no con�icts of interest.
Acknowledgments
is study was funded by the Finnish Cultural Foundation-
Pirkanmaa Regional Fund, Competitive Research Funding of
the Pirkanmaa Hospital District, Tekes–the Finnish Funding
Agency for Technology and Innovation and Finnish Foun-
dation for Cardiovascular Research. is work is supported
by NanoNextNL, a micro- and nanotechnology consortium
of the Government of e Netherlands and 130 partners.
e authors would like to thank Ms. Henna Venäläinen
and Mr. Markus Haponen for technical assistance, and Ms.
Annemarie Tuin for fruitful discussions and Ms. Heini Huh-
tala for statistical analysis. ey would also like to acknowl-
edge the animal facilities of the University of Tampere.
References
[1] W. Rosamond, K. Flegal, G. Friday et al., “Heart disease and
stroke statistics—2007 Update: a report from the American
Heart Association Statistics Committee and Stroke Statistics
Subcommittee,” Circulation, vol. 115, no. 5, pp. e69–e171, 2007.
[2] D. Hou, E. A. S. Youssef, T. J. Brinton et al., “Radiolabeled
cell distribution aer intramyocardial, intracoronary, and inter-
stitial retrograde coronary venous delivery: implications for
current clinical trials,” Circulation, vol. 112, no. 9, pp. 150–156,
2005.
[3] K. A. Jackson, S. M. Majka, H. Wang et al., “Regeneration of
ischemic cardiac muscle and vascular endothelium by adult
stem cells,” Journal of Clinical Investigation, vol. 107, no. 11, pp.
1395–1402, 2001.
[4] P. Widimsky, M. Penicka, O. Lang et al., “Intracoronary trans-
plantation of bone marrow stem cells: background, techniques,
and limitations,” European Heart Journal, vol. 8, pp. H16–H22,
2006.
[5] M. Yousef, C. M. Schannwell, M. Köstering, T. Zeus, M. Brehm,
and B. E. Strauer, “e BALANCE Study: clinical bene�t
and long-term outcome aer intracoronary autologous bone
marrow cell transplantation in patients with acute myocardial
infarction,” Journal of the American College of Cardiology, vol.
53, no. 24, pp. 2262–2269, 2009.
[6] B. Assmus, V. Schächinger, C. Teupe et al., “Transplantation
of progenitor cells and regeneration enhancement in acute
myocardial infarction (TOPCARE-AMI),”Circulation, vol. 106,
no. 24, pp. 3009–3017, 2002.
[7] J. H. Traverse, T. D. Henry, D. E. Vaughn et al., “Rationale
and design for TIME: a phase II, randomized, double-blind,
placebo-controlled pilot trial evaluating the safety and eﬀect
of timing of administration of bone marrow mononuclear cells
aer acute myocardial infarction,” American Heart Journal, vol.
158, no. 3, pp. 356–363, 2009.
[8] A. Callegari, S. Bollini, L. Iop et al., “Neovascularization
induced by porous collagen scaﬀold implanted on intact and
cryoinjured rat hearts,” Biomaterials, vol. 28, no. 36, pp.
5449–5461, 2007.
[9] T. Shimizu, M. Yamato, Y. Isoi et al., “Fabrication of pulsatile
cardiac tissue gras using a novel 3-dimensional cell sheet
manipulation technique and temperature-responsive cell cul-
ture surfaces,” Circulation Research, vol. 90, no. 3, article e40,
2002.
[10] W. H. Zimmermann, C. Fink, D. Kralisch, U. Remmers, and J.
Weil, “ree-dimensional engineered heart tissue from neona-
tal rat cardiac myocytes,” Biotechnology and Bioengineering, vol.
68, pp. 106–114, 2000.
[11] M. Radisic, M. Euloth, L. Yang, R. Langer, L. E. Freed, and G.
Vunjak-Novakovic, “High-density seeding of myocyte cells for
cardiac tissue engineering,” Biotechnology and Bioengineering,
vol. 82, no. 4, pp. 403–414, 2003.
[12] K. L. Christman, H. H. Fok, R. E. Sievers, Q. Fang, and R. J.
Lee, “Fibrin glue alone and skeletalmyoblasts in a �brin scaﬀold
preserve cardiac function aer myocardial infarction,” Tissue
Engineering, vol. 10, no. 3-4, pp. 403–409, 2004.
[13] K. R. Stevens, K. L. Kreutziger, S. K. Dupras et al., “Physiological
function and transplantation of scaﬀold-free and vascularized
human cardiac muscle tissue,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 106,
no. 39, pp. 16568–16573, 2009.
[14] L. Ikonen, E. Kerkela, K. Kujala, A. Haaparanta -M, and N.
Ahola, “Analysis of diﬀerent natural and synthetic biomaterials
to support cardiomyocyte growth,” Journal of Clinical and
Experimental Cardiology. In press.
12 BioMed Research International
[15] K. J. C. Van Bommel, C. Van Der Pol, I. Muizebelt et al.,
“Responsive cyclohexane-based low-molecular-weight hydro-
gelators with modular architecture,” Angewandte Chemie, vol.
43, no. 13, pp. 1663–1667, 2004.
[16] K. J. C. Van Bommel, M. C. A. Stuart, B. L. Feringa, and J. Van
Esch, “Two-stage enzyme mediated drug release from LMWG
hydrogels,” Organic and Biomolecular Chemistry, vol. 3, no. 16,
pp. 2917–2920, 2005.
[17] F. Li,G. Palaniswamy,M.R. de Jong et al., “Nanowires formedby
the Co-assembly of a negatively charged low-molecular weight
gelator and a zwitterionic polythiophene,” ChemPhysChem, vol.
11, no. 9, pp. 1956–1960, 2010.
[18] A. Brizard, M. Stuart, K. Van Bommel, A. Friggeri, M. De Jong,
and J. Van Esch, “Preparation of nanostructures by orthogonal
self-assembly of hydrogelators and surfactants,” Angewandte
Chemie, vol. 47, no. 11, pp. 2063–2066, 2008.
[19] I. Kusters,N.Mukherjee,M. R. de Jong, S. Tans, A.Koçer, andA.
J.M.Driessen, “Tamingmembranes: functional immobilization
of biological membranes in hydrogels,” PLoS ONE, vol. 6, no. 5,
Article ID e20435, 2011.
[20] M. R. de Jong, E. Bulten, and S. C. D. van Ijzendoorn, “Self-
assembled nano�ber scaﬀolds,” Journal of Controlled Release,
vol. 132, pp. e19–e36, 2008.
[21] S. Chlopcikova, J. Psotova, and P. Miketova, “Neonatal rat
cardiomyocytes—a model for the study of morphological, bio-
chemical and electrophysiological characteristics of the heart,”
Biomedical papers of the Medical Faculty of the University
Palacký, Olomouc, vol. 145, pp. 49–55, 2001.
[22] K. Shapira-Schweitzer, M. Habib, L. Gepstein, and D. Seliktar,
“A photopolymerizable hydrogel for 3-D culture of human
embryonic stem cell-derived cardiomyocytes and rat neonatal
cardiac cells,” Journal of Molecular and Cellular Cardiology, vol.
46, no. 2, pp. 213–224, 2009.
[23] Y. Duan, Z. Liu, J. O’Neill, L. Q. Wan, D. O. Freytes, and
G. Vunjak-Novakovic, “Hybrid gel composed of native heart
matrix and collagen induces cardiac diﬀerentiation of human
embryonic stem cells without supplemental growth factors,”
Journal of Cardiovascular Translational Research, vol. 4, pp.
605–615, 2011.
[24] O. Caspi, A. Lesman, Y. Basevitch et al., “Tissue engineering of
vascularized cardiacmuscle fromhuman embryonic stem cells,”
Circulation Research, vol. 100, no. 2, pp. 263–272, 2007.
[25] L. W. Chow, R. Bitton, M. J. Webber et al., “A bioactive self-
assembled membrane to promote angiogenesis,” Biomaterials,
vol. 32, no. 6, pp. 1574–1582, 2011.
[26] P. A. Uusimaa, I. E. Hassinen, O. Vuolteenaho, and H.
Ruskoaho, “Endothelin-induced atrial natriuretic peptide re-
lease from cultured neonatal cardiac myocytes: the role of
extracellular calcium and protein kinase-C,” Endocrinology, vol.
130, no. 5, pp. 2455–2464, 1992.
[27] J. A. omson, J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz,
and J. J. Swiergiel, “Embryonic stem cell lines derived from
human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147,
1998.
[28] M. Pekkanen-Mattila, E. Kerkelä, J. M. A. Tanskanen et al.,
“Substantial variation in the cardiac diﬀerentiation of human
embryonic stem cell lines derived and propagated under the
same conditions—a comparison of multiple cell lines,” Annals
of Medicine, vol. 41, no. 5, pp. 360–370, 2009.
[29] A. P. Pêgo, A. A. Poot, D.W. Grijpma, and J. Feijen, “Biodegrad-
able elastomeric scaﬀolds for so tissue engineering,” Journal of
Controlled Release, vol. 87, no. 1–3, pp. 69–79, 2003.
[30] H. Cui, M. J. Webber, and S. I. Stupp, “Self-assembly of
peptide amphiphiles: from molecules to nanostructures to
biomaterials,” Biopolymers, vol. 94, no. 1, pp. 1–18, 2010.
[31] D. A. Narmoneva, O. Oni, A. L. Sieminski et al., “Self-
assembling short oligopeptides and the promotion of angiogen-
esis,” Biomaterials, vol. 26, no. 23, pp. 4837–4846, 2005.
[32] D. D. Allison and K. J. Grande-Allen, “Review. Hyaluronan: a
powerful tissue engineering tool,”Tissue Engineering, vol. 12, no.
8, pp. 2131–2140, 2006.
[33] A. D. Baldwin and K. L. Kiick, “Polysaccharide-modi�ed
synthetic polymeric biomaterials,” Biopolymers, vol. 94, no. 1,
pp. 128–140, 2010.
[34] D. Mazia, G. Schatten, and W. Sale, “Adhesion of cells to
surfaces coated with polylysine. Applications to electron
microscopy,” Journal of Cell Biology, vol. 66, no. 1, pp. 198–200,
1975.
[35] T. Ushiki, “Collagen �bers, reticular �bers and elastic �bers.
A comprehensive understanding from a morphological view-
point,” Archives of Histology and Cytology, vol. 65, no. 2, pp.
109–126, 2002.
[36] E. Bettiol, S. Clement, K. H. Krause, and M. E. Jaconi, “Embry-
onic and adult stem cell-derived cardiomyocytes: lessons from
in vitro models,” Reviews of Physiology, Biochemistry and
Pharmacology, vol. 157, pp. 1–30, 2006.
[37] C. Kim, M. Majdi, P. �ia et al., “Non-cardiomyocytes in�uence
the electrophysiological maturation of human embryonic stem
cell-derived cardiomyocytes during diﬀerentiation,” Stem Cells
and Development, vol. 19, no. 6, pp. 783–795, 2010.
[38] A. Lesman, M. Habib, O. Caspi et al., “Transplantation of a
tissue-engineered human vascularized cardiac muscle,” Tissue
Engineering Part A, vol. 16, no. 1, pp. 115–125, 2010.
[39] J. Leor, S. Gerecht, S. Cohen et al., “Human embryonic stem cell
transplantation to repair the infarctedmyocardium,”Heart, vol.
93, no. 10, pp. 1278–1284, 2007.
[40] M. Habib, K. Shapira-Schweitzer, O. Caspi et al., “A com-
bined cell therapy and in-situ tissue-engineering approach for
myocardial repair,” Biomaterials, vol. 32, pp. 7514–7523, 2011.
[41] L. R. Madden, D. J. Mortisen, E. M. Sussman et al., “Proan-
giogenic scaﬀolds as functional templates for cardiac tissue
engineering,” Proceedings of the National Academy of Sciences of
the United States of America, vol. 107, no. 34, pp. 15211–15216,
2010.
[42] S. Schaaf, A. Shibamiya, M. Mewe, A. Eder, and A. Stohr,
“Human engineered heart tissue as a versatile tool in basic
research and preclinical toxicology,” PLoS ONE, vol. 6, Article
ID e26397, 2011.
[43] O. Caspi, I. Itzhaki, I. Kehat et al., “In vitro electrophysiological
drug testing using human embryonic stem cell derived car-
diomyocytes,” Stem Cells and Development, vol. 18, no. 1, pp.
161–172, 2009.
[44] S. R. Braam, L. Tertoolen, A. van de Stolpe, T. Meyer, R. Passier,
and C. L. Mummery, “Prediction of drug-induced cardiotoxic-
ity using human embryonic stem cell-derived cardiomyocytes,”
Stem Cell Research, vol. 4, no. 2, pp. 107–116, 2010.










Hindawi Publishing Corporation 
http://www.hindawi.com













Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Bioinformatics
Advances in
Marine Biology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Signal Transduction
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Evolutionary Biology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Biochemistry 
Research International
Archaea
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Genetics 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Virolog y
Hindawi Publishing Corporation
http://www.hindawi.com
Nucleic Acids
Journal of
Volume 2014
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Enzyme 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Microbiology
